Drugs / pneumococcal vaccine polyvalent
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05815264 Comparator | Sep 2020 → Apr 2021 | pneumonia | Ab&B Bio-tech Co., Ltd.JS | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pneumococcal vaccine polyvalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05815264 ↗ |
| Modality | Vaccine | “pneumococcal vaccine polyvalent” NCT05815264 ↗ |